Evidence map›Paper›PMID 23768790›Full record

ArticleJournal of vascular surgery2014

Loss of the hyaluronan receptor RHAMM prevents constrictive artery wall remodeling.

Xue Ma, Jeffrey D Pearce, David B Wilson, William P English, Matthew S Edwards, Randolph L Geary

Abstract read
In one paragraph

Article in Journal of vascular surgery, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Cardiovascular Effects Mediated by HMMR and CD44.Mediators of inflammation · 2021
    Review
  4. The Receptor for Hyaluronan-Mediated Motility (CD168) promotes inflammation and fibrosis after acute lung injury.Matrix biology : journal of the International Society for Matrix Biology · 2019
    Article
  5. Article
  6. Article
  7. Deletion of Hyaluronan Synthase 3 Inhibits Neointimal Hyperplasia in Mice.Arteriosclerosis, thrombosis, and vascular biology · 2016
    Article
  8. Hyaluronan as a therapeutic target in human diseases.Advanced drug delivery reviews · 2016
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Xue MaDepartment of Vascular and Endovascular Surgery, Wake Forest University Health Sciences, Winston-Salem, NC.
Jeffrey D PearceDepartment of Vascular and Endovascular Surgery, Wake Forest University Health Sciences, Winston-Salem, NC.
David B WilsonDepartment of Vascular and Endovascular Surgery, Wake Forest University Health Sciences, Winston-Salem, NC.
William P EnglishDepartment of Vascular and Endovascular Surgery, Wake Forest University Health Sciences, Winston-Salem, NC.
Matthew S EdwardsDepartment of Vascular and Endovascular Surgery, Wake Forest University Health Sciences, Winston-Salem, NC.
Randolph L GearyDepartment of Vascular and Endovascular Surgery, Wake Forest University Health Sciences, Winston-Salem, NC. Electronic address: rgeary@wakehealth.edu.
Wake Forest University · US

Funding

ARTERY WALL CONTRACTION, WOUND HEALING, AND RESTENOSISR01HL057557 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI GEARY, RANDOLPH L. · 1998 to 2006
$1.9M
NHLBI NIH HHS R01 HL057557NHLBI NIH HHS R01HL57557
6 · The paper itself

Abstract

objectiveConstrictive extracellular matrix (ECM) remodeling contributes significantly to restenosis after arterial reconstruction, but its molecular regulation is poorly defined. Hyaluronan (HA) accumulates within ECM at sites of injury where it is thought to facilitate smooth muscle cell (SMC) trafficking and collagen remodeling analogous to its role in cutaneous wound healing. SMC receptors for HA include receptor for hyaluronan-mediated motility (RHAMM), which mediates HA-induced migration. We hypothesized RHAMM would also mediate SMC-matrix interactions to alter the extent of constrictive remodeling.

methodsWe studied the role of RHAMM in SMC attachment to collagen, migration, and contraction of collagen gels using blocking antibodies and SMC from RHAMM -/- knockout mice. We then determined the role of RHAMM in constrictive artery wall remodeling by comparing changes in wall geometry in RHAMM -/- vs wild-type (WT) RHAMM +/+ controls 1 month after carotid ligation.

resultsHA increased SMC attachment to collagen-coated plates, but blocking RHAMM reduced adhesion (P = .025). RHAMM -/- SMC also demonstrated reduced adhesion (% adherent: 36.1 ± 2.2 vs 76.3 ± 1.9; P < .05). SMC contraction of collagen gels was enhanced by HA and further increased by RHAMM blockade (P < .01) or knockout (gel diameter, mm: RHAMM -/-, 6.7 ± 0.1 vs WT 9.8 ± 0.1; P < .01). RHAMM promoted constrictive remodeling in vivo as carotid artery size was significantly larger in knockout mice 1 month after ligation. Neointimal thickening, however, was not affected in RHAMM -/- (P = NS vs WT), but lumen size was significantly larger (lumen area, μm(2): 52.4 ± 1.4 × 10(3) vs 10.4 ± 1.8 × 10(3); P = .01) because artery size constricted less (external elastic lamina area, μm(2): RHAMM -/-, 92.4 ± 4.7 × 10(3) vs WT, 51.3 ± 5.9 × 10(3); P = .015). Adventitial thickening and collagen deposition were also more extensive in ligated RHAMM -/- carotids (adventitial thickness, μm: 218 ± 12.2 vs 109 ± 7.9; P = .01).

conclusionsHA activation of RHAMM significantly impacts SMC-ECM adhesive interactions and contributes to constrictive artery wall remodeling in mice. Strategies to block RHAMM at sites of vessel injury may prove useful in the prevention of clinical restenosis.

Indexed as

AnimalsCarotid ArteriesCarotid StenosisCell AdhesionCell MovementCells, CulturedCell ShapeCollagen Type IDisease Models, AnimalExtracellular Matrix ProteinsHyaluronan ReceptorsHyaluronic AcidHyperplasiaMiceMice, Inbred C57BLMice, KnockoutCollagen Type IExtracellular Matrix Proteinshyaluronan-mediated motility receptorHyaluronan ReceptorsHyaluronic Acid

Identifiers

PMID23768790
PMCPMC3844090
OpenAlexW1986693322

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.